
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.01 | 1.22 | 0.21 |
Shares | 98.99 | 99.01 | 0.02 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.46 | 19.61 |
Price to Book | 3.76 | 3.87 |
Price to Sales | 2.05 | 2.21 |
Price to Cash Flow | 12.45 | 14.70 |
Dividend Yield | 2.15 | 1.50 |
5 Years Earnings Growth | 7.93 | 9.83 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.54 | 95.06 |
Basic Materials | 0.39 | 1.76 |
Consumer Defensive | 0.04 | 3.09 |
Financial Services | 0.03 | 7.47 |
Number of long holdings: 181
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.29 | 732.58 | +0.08% | |
J&J | US4781601046 | 5.33 | 177.14 | +0.96% | |
AbbVie | US00287Y1091 | 4.66 | 210.40 | +1.19% | |
UnitedHealth | US91324P1021 | 3.96 | 309.80 | +2.48% | |
Abbott Labs | US0028241000 | 3.27 | 132.66 | +0.98% | |
Novartis | CH0012005267 | 3.24 | 101.16 | -0.37% | |
Roche Holding Participation | CH0012032048 | 3.22 | 260.30 | -0.27% | |
Novo Nordisk B | DK0062498333 | 3.11 | 358.8 | 0.00% | |
Intuitive Surgical | US46120E6023 | 2.77 | 473.45 | -0.08% | |
Merck&Co | US58933Y1055 | 2.77 | 84.13 | +1.10% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
International Index Trust I Acc | 1.38B | 6.18 | 13.15 | 12.86 | ||
International Index Trust I Dist | 302.77M | 6.20 | 13.14 | 12.85 | ||
International Index Trust R Acc | 38.69M | 5.97 | 12.71 | 12.31 | ||
International Index Trust R Dist | 938.73K | 6.00 | 12.73 | 12.31 | ||
Legal General US Index Trust C Acc | 3.15B | -9.46 | 8.17 | 13.30 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review